Stelo Glucose Biosensor

About Dexcom

Dexcom has established itself as the market leader in continuous glucose monitoring technology over 25 years, transforming diabetes care with real-time glucose tracking that eliminates the need for fingerstick testing. The company's flagship Dexcom G7 system represents the most accurate CGM technology available, while their new Stelo biosensor expands their addressable market to people without diabetes seeking metabolic health insights. With a strong commercial presence and robust innovation pipeline, Dexcom continues to set the standard in glucose biosensing technology.

Therapeutic Areas